Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma

Anticancer Research

Volumn 23, Issue 3 C, 2003, Pages 3051-3056

  Atula, Timo ^a   Hedström, Johan ^a   Finne, Patrik ^a   Leivo, Ilmo ^a   Markkanen Leppänen, Mari ^a   Haglund, Caj ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Malignancy; Metastasis; Oral; Pharyngeal; Prognosis; Tenascin

Indexed keywords

BIOLOGICAL MARKER; TENASCIN;

ADULT; AGED; ARTICLE; BIOACCUMULATION; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PHARYNX CARCINOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; TISSUE DISTRIBUTION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PHARYNGEAL NEOPLASMS; PROGNOSIS; STROMAL CELLS; TENASCIN;

EID: 0041621875     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bailey BJ: Beyond the "New" TNM classification. Arch Otolaryngol Head Neck Surg 117: 369-370, 1991.
2. Quon H, Liu FF and Cummings BJ: Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 23: 147-159, 2001.
3. Sakakura T and Kusakabe M: Can tenascin be redundant in cancer development? Perspect Dev Neurobiol 2: 111-116, 1994.
4. Hindermann W, Berndt A, Borsi L, Luo X, Hyckel P, Katenkamp D and Kosmehl H: Synthesis and protein distribution of unspliced large tenascin-C isoform in oral squamous cell carcinoma. J Pathol 189: 474-480, 1999.
5. Yoshida T, Yoshimura E, Numata H, Sakakura Y and Sakakura T: Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells. Virchows Archiv 435: 496-500, 1999.
6. Iskaros BF, Tanaka KE, Hu X, Kadish AS and Steinberg JB: Morphologic pattern of tenascin as a diagnostic biomarker of colon cancer. J Surg Oncol 64: 98-101, 1997.
7. Iskaros BF, Hu X, Sparano JA and Fineberg SA: Tenascin pattern of expression and established prognostic factors in invasive breast carcinoma. J Surg Oncol 68: 107-112, 1998.
8. Kärjä V, Syrjänen K and Syrjänen S: Collagen IV and tenascin immunoreactivity as prognostic determinant in benign and malignant salivary gland tumours. Acta Otolaryngol (Stockh) 115: 569-575, 1995.
9. Ilunga K and Iriyama K: Expression of tenascin in gastric carcinoma. Br J Surg 82: 948-951, 1995.
10. Jahkola T, Toivonen T, von Smitten K, Blomqvist C and Virtanen I: Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis. Int J Cancer 69: 445-447, 1996.
11. Jahkola T, Toivonen T, Virtanen I, von Smitten K, Nordling S, von Boguslawski K, Haglund C, Nevanlinna H and Blomqvist C: Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer 78: 1507-1513, 1998.
12. Salmenkivi K, Haglund C, Arola J and Heikkilä P: Increased expression of tenascin in pheochromocytomas correlates with malignancy. Am J Surg Pathol 25: 1419-1423, 2001.
13. Tiitta O, Happonen RP, Virtanen I and Luomanen M: Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma. J Oral Pathol Med 23: 446-450, 1994.
14. Harada T, Shinohara M, Nakamura S and Oka M: An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchows Archiv 424: 257-266, 1994.
15. Anbazhagan R, Sakakura T and Gusterson BA: The distribution of immuno-reactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia. Virchows Archiv B Cell Pathol 59: 59-63, 1990
16. Juhasz A, Bardos H, Repassy G and Adany R: Characteristic distribution patterns of tenascin in laryngeal and hypopharyngeal cancers. Laryngoscope 110: 84-92, 2000.
17. Soini Y, Pääkko P, Nuorva K, Kamel D, Linnala A, Virtanen I and Lehto V-P: Tenascin immunoreactivity in lung tumors. Am J Clin Pathol 100: 145-150, 1993.
18. Pearson CA, Pearson D, Shibahara S, Hofsteenge J and Chiquet-Ehrismann R: Tenascin: cDNA cloning and introduction of TGF-beta. EMBO J 7: 2977-2981, 1998.
19. Lightner VA and Erickson HP: Binding of hexabrachion (tenascin) to the extracellular matrix and substratum and its effect on cell adhesion. J Cell Sci 95: 263-277, 1990.
20. Tiitta O, Luomanen M, Hietanen J and Virtanen I: Tenascin expression in mucocutaneous diseases and related lesions of oral mucosa. Arch Oral Biol 40: 1039-1045, 1995.
21. Regezi JA, Ramos DM, Pytela R, Dekker NP and Jordan RCK: Tenascin and 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncology 38: 332-336, 2002.